Fig. 1From: Docetaxel chemotherapy plus androgen-deprivation therapy in high-volume disease metastatic hormone-sensitive prostate cancer in Chinese patients: an efficacy and safety analysisA comparison of PFS curves of patients in the combined DTX group and the ADT groupBack to article page